Aperio Clinical Outcomes has appointed Cari Kniola to lead its strategy for existing and continued growth, the company said in a statement Thursday.

Kniola is currently Aperio’s director of corporate strategy and has over 20 years of clinical research experience in the medical device and pharma industries.

“We want to make sure to continue to grow Aperio in a way that maximizes our potential while being true to who we are, all the while providing our services with the utmost quality and integrity,” said Fay Woolf, Aperio’s founder and chief executive officer.

Aperio is a leading clinical research organization that provides customizable research services across multiple therapeutic areas.

“I am excited to take both my ‘real world’ experience and my innate skills and use them together to help strategize the growth of Aperio,” said Kniola.